Class IIITerminatedD-0667-2017
Drug recall · April 19, 2017
Lumigan recall
Why: Failed Impurities/Degradation Specifications
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Lumigan (bimatoprost ophthalmic solution) 0.01%, 7.5 mL bottle, Rx only, Allergan Irvine, CA 92612, NDC 0023-3205-08.
- Lots / codes
Lot #: 92577, Exp. JUN 2018
- Quantity
- 56,878 bottles
- Company
- Allergan Sales, LLC, Waco, TX
- Distribution
- Nationwide in the US
- Initiated
- March 16, 2017 · Voluntary: Firm initiated
- Classified
- April 12, 2017
- Reported
- April 19, 2017
- Ended
- May 1, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lumigan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.